205 related articles for article (PubMed ID: 28462869)
21. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
22. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial.
Clark LV; Pesola F; Thomas JM; Vergara-Williamson M; Beynon M; White PD
Lancet; 2017 Jul; 390(10092):363-373. PubMed ID: 28648402
[TBL] [Abstract][Full Text] [Related]
23. Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer.
Poort H; Verhagen CA; Peters ME; Goedendorp MM; Donders AR; Hopman MT; Nijhuis-van der Sanden MW; Berends T; Bleijenberg G; Knoop H
BMC Cancer; 2017 Jan; 17(1):81. PubMed ID: 28129746
[TBL] [Abstract][Full Text] [Related]
24. Potential mechanisms involved in the effect of cognitive behavioral therapy on fatigue severity in Type 1 diabetes.
Menting J; Tack CJ; Donders R; Knoop H
J Consult Clin Psychol; 2018 Apr; 86(4):330-340. PubMed ID: 29648854
[TBL] [Abstract][Full Text] [Related]
25. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial.
Stulemeijer M; de Jong LW; Fiselier TJ; Hoogveld SW; Bleijenberg G
BMJ; 2005 Jan; 330(7481):14. PubMed ID: 15585538
[TBL] [Abstract][Full Text] [Related]
26. Internet-Based Cognitive Behavioral Therapy for Chronic Fatigue Syndrome Integrated in Routine Clinical Care: Implementation Study.
Worm-Smeitink M; van Dam A; van Es S; van der Vaart R; Evers A; Wensing M; Knoop H
J Med Internet Res; 2019 Oct; 21(10):e14037. PubMed ID: 31603428
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial.
Nijhof SL; Bleijenberg G; Uiterwaal CS; Kimpen JL; van de Putte EM
Lancet; 2012 Apr; 379(9824):1412-8. PubMed ID: 22385683
[TBL] [Abstract][Full Text] [Related]
28. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study.
Raijmakers RPH; Keijmel SP; Breukers EMC; Bleijenberg G; van der Meer JWM; Bleeker-Rovers CP; Knoop H
J Psychosom Res; 2019 Jan; 116():62-67. PubMed ID: 30654996
[TBL] [Abstract][Full Text] [Related]
29. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
[TBL] [Abstract][Full Text] [Related]
30. Randomised controlled trial of cognitive behaviour therapy delivered in groups of patients with chronic fatigue syndrome.
Wiborg JF; van Bussel J; van Dijk A; Bleijenberg G; Knoop H
Psychother Psychosom; 2015; 84(6):368-76. PubMed ID: 26402868
[TBL] [Abstract][Full Text] [Related]
31. Cognitive behavioural therapy stabilises glycaemic control in adolescents with type 1 diabetes-Outcomes from a randomised control trial.
Wei C; Allen RJ; Tallis PM; Ryan FJ; Hunt LP; Shield JP; Crowne EC
Pediatr Diabetes; 2018 Feb; 19(1):106-113. PubMed ID: 28419661
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
Aroda VR; Bain SC; Cariou B; Piletič M; Rose L; Axelsen M; Rowe E; DeVries JH
Lancet Diabetes Endocrinol; 2017 May; 5(5):355-366. PubMed ID: 28344112
[TBL] [Abstract][Full Text] [Related]
33. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.
Voet NB; Bleijenberg G; Padberg GW; van Engelen BG; Geurts AC
BMC Neurol; 2010 Jun; 10():56. PubMed ID: 20591139
[TBL] [Abstract][Full Text] [Related]
34. Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial.
Tovote KA; Fleer J; Snippe E; Peeters AC; Emmelkamp PM; Sanderman R; Links TP; Schroevers MJ
Diabetes Care; 2014 Sep; 37(9):2427-34. PubMed ID: 24898301
[TBL] [Abstract][Full Text] [Related]
35. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
[TBL] [Abstract][Full Text] [Related]
36. Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: long-term follow-up of an RCT.
Lloyd S; Chalder T; Rimes KA
Behav Res Ther; 2012 Nov; 50(11):719-25. PubMed ID: 22985998
[TBL] [Abstract][Full Text] [Related]
37. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study.
Bazelmans E; Prins JB; Lulofs R; van der Meer JW; Bleijenberg G;
Psychother Psychosom; 2005; 74(4):218-24. PubMed ID: 15947511
[TBL] [Abstract][Full Text] [Related]
38. The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance.
Knoop H; Prins JB; Stulemeijer M; van der Meer JW; Bleijenberg G
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):434-6. PubMed ID: 17369597
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
